We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+10.83%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$366M
AUM Growth
+$30.5M
Cap. Flow
-$2.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
28.66%
Holding
113
New
5
Increased
29
Reduced
34
Closed
1

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$980K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$628K
3
T icon
AT&T
T
+$566K
4
AAPL icon
Apple
AAPL
+$417K
5
WU icon
Western Union
WU
+$251K

Sector Composition

Rank Sector Weight
1 Technology 15.04%
2 Healthcare 13.93%
3 Industrials 11.85%
4 Consumer Staples 10.75%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.85T
$17.9M 4.9%
53,345
-3,023
-5% -$980K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$878B
$14.4M 3.94%
30,265
+171
+0.6% +$78.8K
AAPL icon
3
Apple
AAPL
$4.89T
$10.8M 2.95%
60,823
-2,640
-4% -$417K
TSCO icon
4
Tractor Supply
TSCO
$16B
$9.81M 2.68%
205,580
-4,775
-2% -$209K
FAST icon
5
Fastenal
FAST
$53.5B
$9.61M 2.62%
299,900
-3,290
-1% -$97K
ACN icon
6
Accenture
ACN
$89B
$9.06M 2.47%
21,856
-277
-1% -$101K
CSCO icon
7
Cisco
CSCO
$449B
$8.82M 2.41%
139,228
-585
-0.4% -$33.4K
ABT icon
8
Abbott
ABT
$180B
$8.34M 2.28%
59,251
-115
-0.2% -$14.7K
IJR icon
9
iShares Core S&P Small-Cap ETF
IJR
$109B
$8.22M 2.24%
71,794
+1
+0% +$114
ABBV icon
10
AbbVie
ABBV
$458B
$7.94M 2.17%
58,663
-195
-0.3% -$23K
MA icon
11
Mastercard
MA
$472B
$7.83M 2.14%
21,792
+197
+0.9% +$68.1K
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$3.91T
$7.64M 2.09%
52,780
-4,360
-8% -$628K
XYL icon
13
Xylem
XYL
$28.3B
$7.54M 2.06%
62,897
+255
+0.4% +$31.6K
PG icon
14
Procter & Gamble
PG
$343B
$7.46M 2.04%
45,621
+10
+0% +$1.49K
UPS icon
15
United Parcel Service
UPS
$97.4B
$7.22M 1.97%
33,678
-80
-0.2% -$16.3K
GIS icon
16
General Mills
GIS
$19.2B
$7.01M 1.92%
104,119
+240
+0.2% +$15.2K
WMT icon
17
Walmart Inc
WMT
$868B
$6.85M 1.87%
142,119
+495
+0.3% +$23.6K
LH icon
18
Labcorp
LH
$24.2B
$6.82M 1.86%
25,262
-123
-0.5% -$30.4K
MCD icon
19
McDonald's
MCD
$189B
$6.72M 1.83%
25,064
-17
-0.1% -$4.29K
CVS icon
20
CVS Health
CVS
$137B
$6.69M 1.83%
64,851
-184
-0.3% -$17K
PEP icon
21
PepsiCo
PEP
$186B
$6.59M 1.8%
37,948
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.07T
$6.07M 1.66%
20,285
-35
-0.2% -$10K
LIN icon
23
Linde
LIN
$236B
$6.06M 1.66%
17,500
-214
-1% -$69.3K
IEMG icon
24
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$5.77M 1.58%
96,462
+85
+0.1% +$5.25K
CHRW icon
25
C.H. Robinson
CHRW
$22.2B
$5.34M 1.46%
49,587
-20
-0% -$1.94K

Similar funds

Boston Research & Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Research & Management held 113 positions worth $366M, up 9.1% from $336M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Research & Management's Q4 2021 filing shows 5 new, 29 increased, 34 reduced and 1 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 2,684 shares worth $287K. The largest sale was Microsoft, an estimated $980K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Research & Management's largest Q4 2021 buy was iShares Core S&P Total US Stock Market ETF: 2,684 shares worth $287K.
  • Boston Research & Management added most to Magna International in Q4 2021, an estimated $326K increase.
  • Boston Research & Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $980K.
  • Boston Research & Management fully exited Texas Instruments in Q4 2021, selling an estimated $203K.
  • Boston Research & Management's ten largest holdings make up 29% of its $366M portfolio in Q4 2021.
  • Boston Research & Management opened 5 new positions and closed 1 in Q4 2021.
  • Boston Research & Management's portfolio value rose 9.1% quarter-over-quarter to $366M.

Based on Boston Research & Management's 13F filing for Q4 2021, filed 10 Feb 2022.